MedPath

Brain Mechanisms of Reducing Polysubstance Use

Not Applicable
Recruiting
Conditions
Multiple Drug Use
Registration Number
NCT06324786
Lead Sponsor
Arizona State University
Brief Summary

The proposed study will test whether neurofeedback (NF) could optimize integrative body-mind training (IBMT) practice.

Detailed Description

The proposed study will test whether real-time NF could optimize IBMT practice and improve effects in reducing polysubstance use through targeting self-control networks in the brain.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
35
Inclusion Criteria
  • At least 18 years old
  • Free of any psychiatric diagnoses or medication (besides a substance use disorder (SUD) to alcohol, tobacco, or cannabis)
  • In the past month, at least 4 episodes of heavy episodic drinking; at least 3 occasions of cannabis use; and daily cigarette use for at least the past month
  • Normal or corrected-to-normal vision
  • Written informed consent
  • No previous meditation or NF experiences
Exclusion Criteria
  • Any psychiatric diagnoses other than an SUD
  • Medical disorder(s) that may affect the central nervous system; medications that affect the central and autonomic nervous system; or a positive pregnancy test result (females)
  • Excluding cannabis, evidence of recent (past month) illicit drug use

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Intervention effects on brain grey matter using fMRIThe outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

Brain volume changes such as anterior and posterior cingulate cortex measured by fMRI structural imaging

Intervention effects on brain white matter using fMRIThe outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

Brain white matter changes such as anterior and posterior cingulate cortex measured by fMRI diffusion tensor imaging

Intervention effects on brain function using Functional Magnetic Resonance Imaging (fMRI)The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

Brain connectivity changes such as anterior and posterior cingulate cortex measured by fMRI resting state imaging

Secondary Outcome Measures
NameTimeMethod
Intervention effects on addiction behavior using substance use questionnaires in PhenX ToolkitThe outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

Intervention leads to a significant reduction in craving and substance use measured by substance use questionnaires in PhenX Toolkit

Trial Locations

Locations (1)

YiYuan Tang

🇺🇸

Phoenix, Arizona, United States

YiYuan Tang
🇺🇸Phoenix, Arizona, United States
YiYuan Tang
Contact
480-790-3577
yiyuan@asu.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.